Assessment of Frequency of Surveillance After Curative Resection in Patients With Stage II and III Colorectal Cancer
Colorectal Cancer
About this trial
This is an interventional treatment trial for Colorectal Cancer focused on measuring Follow-up
Eligibility Criteria
Inclusion Criteria: Radical surgery (R0-resection) for colorectal adenocarcinoma - with or without adjuvant treatment Age < 75 years Provision of written informed consent for participation "Clean colon" verified by perioperative barium enema or colonoscopy last 3 months post-surgery Tumour stage: II-III (Tany N1-2 M0, T3-4NanyM0, Dukes´ B - C) Exclusion Criteria: A clinical diagnosis of HNPCC (non hereditary polyposis colorectal cancer) or FAP (familial polyposis coli) Local resection for colorectal cancer (e.g., TEM-procedure) Life-expectancy less than 2 years due to concurrent disease (e.g., cardiac disease, terminal multiple sclerosis, liver cirrhosis) Inability to provide informed consent or refusal to do so Inability to comply with the control or intense follow-up program Participation in other clinical trials interfering with the control-programs Previous malignancies (except for non-melanoma skin cancer)
Sites / Locations
- Peer Wille-Jørgensen
Arms of the Study
Arm 1
Arm 2
Active Comparator
Other
1 frequent control
2 less frequent control
Follow-up 6, 12, 18, 24 and 36 months after surgery
Follow-up 12 and 36 months after surgery